News

MicroVision (NASDAQ: MVIS) shareholders endured a volatile trading week this week that ultimately led to negative returns. Shares of the computer vision tech specialist were down 25% through

Soon enough, there's a big chance that the plucky biotech Coherus Biosciences (NASDAQ: CHRS) is going to be eating AbbVie's (NYSE: ABBV) lunch. Assuming it does, it's not going to be stealing a fry

The best biotech growth stocks typically have one clear-cut value driver. This fact is a testament to the extreme difficulty involved in bringing a major new drug to market and subsequently

The long, drawn-out sale of English Premier League club Manchester United (NYSE: MANU) seems to be nearing an end, and if reports are to be believed, shareholders will get a payout. The excitement

Shares of MicroVision (NASDAQ: MVIS) are soaring in Thursday's trading. The machine-vision specialist's stock was up 14.1% at 10:30 a.m. ET, according to data from S&P Global Market Intelligence.

You can earn monthly dividend income in a few ways:

Today, I look at three blue chip stocks that are trading at reasonable valuations and will have you receiving a dividend paycheck every month. One

You can earn monthly dividend income in a few ways:

Today, I look at three blue chip stocks that are trading at reasonable valuations and will have you receiving a dividend paycheck every month. One

When looking for bargains at a store, you might go to the sale rack. With the stock market, you might look to some of the stocks that have tumbled over the past several months. Even though the three

When looking for bargains at a store, you might go to the sale rack. With the stock market, you might look to some of the stocks that have tumbled over the past several months. Even though the three

Artificial intelligence (AI) is getting heaps of attention on Wall Street, but that doesn't mean it's the only innovative investment opportunity right now. Shares of plenty of companies that aren't

Shares of healthcare insurer UnitedHealth Group (NYSE: UNH) were down more than 7% Wednesday afternoon after falling as much as 9.3% earlier in the day. The drop in the stock came after comments by

Shares of healthcare insurer UnitedHealth Group (NYSE: UNH) were down more than 7% Wednesday afternoon after falling as much as 9.3% earlier in the day. The drop in the stock came after comments by

The prevailing mood lately on Wall Street has been positive. That has sent a lot of individual stocks higher over the past several weeks, particularly those with technology connections.

Shares of several health insurers were sinking on Wednesday. Centene (NYSE: CNC) stock was down 7.9% as of 12:13 p.m. ET, while CVS Health (NYSE: CVS) and Humana (NYSE: HUM) shares were falling 6.1%

Shares of several health insurers were sinking on Wednesday. Centene (NYSE: CNC) stock was down 7.9% as of 12:13 p.m. ET, while CVS Health (NYSE: CVS) and Humana (NYSE: HUM) shares were falling 6.1%

MicroVision (NASDAQ: MVIS) shareholders continue to see elevated volatility in their portfolios. The computer vision tech specialist's shares were down by 23% as of 10:45 a.m. Wednesday, reversing

According to an old proverb, good things come to those who wait. That tends to be true in the stock market, at least for investors who buy shares of quality companies. Waiting, being patient, and

Investor enthusiasm can wax and wane -- sometimes dramatically. Consider CRISPR Therapeutics (NASDAQ: CRSP), which is trading for around $61 a share, down from its high of $220.20 on Jan. 15, 2021.

Investor enthusiasm can wax and wane -- sometimes dramatically. Consider CRISPR Therapeutics (NASDAQ: CRSP), which is trading for around $61 a share, down from its high of $220.20 on Jan. 15, 2021.

Investor enthusiasm can wax and wane -- sometimes dramatically. Consider CRISPR Therapeutics (NASDAQ: CRSP), which is trading for around $61 a share, down from its high of $220.20 on Jan. 15, 2021.